Although chronic disease management has always been a key principle of preventative healthcare, the ability to integrate hardware and software is still a rare feat amongst MedTech startups but one who is delivering on this is Beijing based Dnurse.
The problem Dnurse is tackling is a significant one. China now has 110 million diabetics, 70% of whom are still undiagnosed, and 80% of the costs relating to diabetes stem from the treatment of complications arising from the mismanagement of diabetes as opposed to inevitable symptoms.
Although a number of chronic disease management services exist, two key innovations have marked out Dnurse as the leading diabetes management platform in China. The first is an insulin pen coupled with an AI driven recommendation engine called the IDSS (Intelligent Decision Supporting System), based on 10,000 medical scenarios.
The IDSS utilizes the processing power of smartphones and Dnurse operated cloud servers to analyse blood glucose levels and insulin dosages in real time before delivering personalised recommendations to diabetes sufferers. This includes The IDSS also integrates with both the patient and doctor Dnurse app, enabling seamless doctor-patient communication and minimising the response time in cases of seizure or overdose.
The second innovation at Dnurse is Insulink, an insulin dosage monitor that records insulin dosages in real time before uploading this data to the Dnurse platform, ultimately helping diabetics to efficiently manage their blood glucose levels and treatment routine. Additionally, Insulink generates a data log that is further analysed by the Dnurse IDSS and again pushed to Dnurse users and user nominated doctors.
Dnurse has also developed a Smart Glucose Meter which includes TRIPLE WELL anti-interference capabilities and a wide range of hematocrit suitable for neonatal and gestational diabetes in addition to a particular long life span of 4000 uses over 5 years.
These actions at Dnurse have not gone unnoticed by pharmaceuticals, diabetes analytics startups and life insurers. Taikang Life recently partnered with Dnurse to launch a diabetes product called ‘Sweet Life’ and Dnurse is now being integrated directly into the homepage of Ping An Good Doctor, bringing access to 300 million active users. Dnurse also has partnerships with a range of global diabetes management solutions including India’s BeatO and Denmark’s Nono-Nordisk.
Ultimately, Dnurse has taken years of hardware experience and applied it to the prevention and management of diabetes, and with over 400 million diabetics worldwide, half of whom are still undiagnosed, the opportunity to prevent to escalation of symptoms is significant and Dnurse has marked itself out with an ability to integrate hardware and software in a way that benefits both consumers and preventative healthcare providers by improving the compliance rate of diabetic.
To read the latest insurance innovation news and features in Chinese on WeChat visit our page at: